Digital cannabis education and analytics company Cannvas MedTech (OTCPK: CANVF) has signed a revenue sharing agreement with Medical Marihuana Patient Relief, a private locally-owned producer based in Tecumseh, Ontario.
The two companies are “jointly deploying technologies to increase value-added services offered between company platforms while driving customer integration,” according to a press statement.
Cannvas plans to use its data analysis capabilities to generate revenue through tracking the number of Cannvas.Me users who choose MM Patient Relief as their primary cannabis provider and can track purchases made throughout the lifetime of a patient.
“Providing MM Patient Relief’s community with better access to cannabis education while Cannvas.Me users gain an option to follow up with MM Patient Relief for their therapeutic cannabis needs, if they so choose, ensures a mutually beneficial scenario”, Steve Loutskou, chief operating officer of global markets at Cannvas MedTech, stated.
Established in 2014, MM Patient Relief is a private, locally-owned business based in Tecumseh, Ontario. The company is focused on creating medical cannabis strains for pain, arthritis, and cancer.
MM Patient Relief is in the final stage of Health Canada MMPR / ACMPR (Access to Cannabis for Medical Purposes Regulation) approval and finalizing construction of its state-of-the-art stand-alone facility.